AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24766747 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal co-morbidity
Number of subjects: 300
Study 24766747 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 300
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia crowns and fixed partial dentures (FPDs) using Cercon, ZirkonZahn, Lava, and Katana systems
Number of subjects: 59
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: Katana zirconia system
Number of subjects: 59
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: Cercon zirconia system
Number of subjects: 59
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: Lava zirconia system
Number of subjects: 59
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported crowns
Number of subjects: 59
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: FPDs
Number of subjects: 59
Study 22545251 — intervention group
Group type: EXPERIMENTAL
Intervention: Katana FPDs
Number of subjects: 59
Study 20235836 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 400 mg twice daily
Number of subjects: 484
Study 20235836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study 20235836 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (with estimated adherence 90%)
Number of subjects: 484
Study 18234565 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous catecholamines (adrenergic group)
Number of subjects: 44
Study 18234565 — intervention group
Group type: COMPARATOR
Intervention: Non-adrenergic treatment (control group)
Number of subjects: 44
Study 15695976 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol 17beta
Number of subjects: 664
Study 15695976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study 12866327 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental case‐based educational modules + personal prescribing feedback
Number of subjects: 207
Study 12866327 — intervention group
Group type: COMPARATOR
Intervention: Experimental case‐based educational modules
Number of subjects: 207
Study 10368449 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline treatment (cumulative doses between 45 and 1150 mg/m2, median 270 mg/m2)
Number of subjects: 125
Study 10368449 — intervention group
Group type: COMPARATOR
Intervention: Control data matched for body surface area
Number of subjects: 125
Study 8654629 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniplant (nomegestrol acetate)
Number of subjects: 15
Study 2050093 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholemeal bread (50 g available carbohydrate)
Number of subjects: 7
Study 2050093 — intervention group
Group type: EXPERIMENTAL
Intervention: White bread (50 g available carbohydrate)
Number of subjects: 7
Study 2050093 — intervention group
Group type: EXPERIMENTAL
Intervention: Grained wholemeal rye bread (50 g available carbohydrate)
Number of subjects: 7
Study 2050093 — intervention group
Group type: EXPERIMENTAL
Intervention: Grained wholemeal rye bread with 40% dried figs (50 g available carbohydrate)
Number of subjects: 7
Study 6407502 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (150 mg daily)
Number of subjects: 32
Study 6407502 — intervention group
Group type: COMPARATOR
Intervention: Chlorimipramine (150 mg daily)
Number of subjects: 32
Study 31365298 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiration Valve System (SVS) with medical management
Number of subjects: 172
Study 31365298 — intervention group
Group type: COMPARATOR
Intervention: Medical management alone
Number of subjects: 172
Study 28954586 — intervention group
Group type: EXPERIMENTAL
Intervention: Night duty (sleep deprivation and fatigue)
Number of subjects: 6
Study 25205320 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic consortium (Lab4) plus 50 mg vitamin C
Number of subjects: 57
Study 25205320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 23752299 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min interruption period
Number of subjects: 311
Study 23752299 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min interruption period
Number of subjects: 311
Study 23752299 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min interruption period
Number of subjects: 311
Study 22332067 — intervention group
Group type: EXPERIMENTAL
Intervention: 120‐kVp MNR group
Number of subjects: 60
Study 22332067 — intervention group
Group type: EXPERIMENTAL
Intervention: 80‐kVp MNR group
Number of subjects: 60
Study 22332067 — intervention group
Group type: EXPERIMENTAL
Intervention: 80‐kVp HNR group
Number of subjects: 60
Study 22332067 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study 19483114 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 1218
Study 19483114 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 1218
Study 16706246 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 1% gel
Number of subjects: 0
Study 15274037 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs (fluvoxamine or paroxetine) for 6 weeks
Number of subjects: 221
Study 11759644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fluconazole for six weeks
Number of subjects: 100
Study 11759644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9043599 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotomy with abrasion arthroplasty (Group A)
Number of subjects: 88
Study 9043599 — intervention group
Group type: COMPARATOR
Intervention: Osteotomy alone (Group B)
Number of subjects: 88
Study 9043599 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 7930766 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiochemotherapy followed by radical surgery
Number of subjects: 268
Study 7930766 — intervention group
Group type: COMPARATOR
Intervention: Radical surgery alone
Number of subjects: 268
Study 3422682 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (two chemotherapeutic regimens)
Number of subjects: 166
Study 3422682 — intervention group
Group type: COMPARATOR
Intervention: Surgical management aspects (interval from first symptoms to definitive surgery, surgical sequence, type of surgery)
Number of subjects: 166
Study 3422682 — intervention group
Group type: COMPARATOR
Intervention: Above knee amputation
Number of subjects: 166
Study 3422682 — intervention group
Group type: COMPARATOR
Intervention: Tibial allograft
Number of subjects: 166
Study 3422682 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy after recurrence
Number of subjects: 166
Study 30875961 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotus Seed (LS)
Number of subjects: 10
Study 30875961 — intervention group
Group type: EXPERIMENTAL
Intervention: Adzuki Bean (AB)
Number of subjects: 10
Study 30875961 — intervention group
Group type: COMPARATOR
Intervention: Waxy Black Rice (BR)
Number of subjects: 10
Study 30875961 — intervention group
Group type: COMPARATOR
Intervention: Other Starchy Foods
Number of subjects: 10
Study 30875961 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotus Seed (LS) and Adzuki Bean (AB)
Number of subjects: 10
Study 30875961 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-soaking
Number of subjects: 10
Study 28368941 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (100 μg)
Number of subjects: 192
Study 28368941 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ropivacaine wound infusion (0.2%)
Number of subjects: 192
Study 28368941 — intervention group
Group type: COMPARATOR
Intervention: Control (NaCl 0.9%)
Number of subjects: 192
Study 28368941 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 192
Study 24443965 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Transition to Parenthood Program
Number of subjects: 13
Study 23418863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Wellness Program (LWP) - 12-week group intervention, one-hour weekly sessions discussing dietary choices, lifestyle, physical activity, and self-esteem.
Number of subjects: 160
Study 23418863 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC) - control group without the lifestyle intervention.
Number of subjects: 160
Study 21198573 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg frovatriptan
Number of subjects: 11
Study 21198573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 18294832 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 13
Study 18294832 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 13
Study 16565362 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose retinol (50,000 IU oral retinol for 30 days)
Number of subjects: 104
Study 16565362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 14687749 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol sclerotherapy
Number of subjects: 22
Study 14687749 — intervention group
Group type: COMPARATOR
Intervention: Silver nitrate insertion
Number of subjects: 22
Study 12220802 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric group intervention
Number of subjects: 37
Study 12220802 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 9805726 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care services offered according to Cochrane Pregnancy and Childbirth Database (PCD) criteria
Number of subjects: 2913
Study 9805726 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal examination, evaluation of pelvic size, dental examination, external version for breech presentation, formal risk score classification
Number of subjects: 2913
Study 9805726 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and laboratory tests
Number of subjects: 2913
Study 9805726 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional 'Western' schedule for ANC
Number of subjects: 2913
Study 7651456 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone (50-800 mg)
Number of subjects: 10
Study 7651456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7651456 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone
Number of subjects: 10
Study 2629642 — intervention group
Group type: EXPERIMENTAL
Intervention: Education programme consisting of two packages of education with four weekly meetings
Number of subjects: 119
Study 2629642 — intervention group
Group type: EXPERIMENTAL
Intervention: Education programme
Number of subjects: 119
Study 5766124 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic oestrogen, stilboestrol
Number of subjects: 0
Study 5766124 — intervention group
Group type: COMPARATOR
Intervention: Pure progestogen, megestrol acetate
Number of subjects: 0
Study 28143731 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 62
Study 28143731 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery
Number of subjects: 62
Study 28143731 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 62
Study 25655226 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-NTX (injections)
Number of subjects: 7687
Study 25655226 — intervention group
Group type: COMPARATOR
Intervention: Non-XR-NTX (control group)
Number of subjects: 7687
Study 23036842 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation and aerobic exercise
Number of subjects: 74
Study 23036842 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic stretching physiotherapy intervention
Number of subjects: 74
Study 23036842 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 74
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol treatment goal (< 4.5 mmol/L)
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides treatment goal (< 1.7 mmol/L)
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol treatment goal (< 2.6 mmol/L)
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL cholesterol treatment goal (> 1.0 mmol/L in men and > 1.3 mmol/L in women)
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure (BP) goal below 130/80 mm Hg
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure (BP) goal below 140/90 mm Hg
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting three treatment goals (HbA1c, BP and cholesterol)
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting two out of three treatment goals
Number of subjects: 1714
Study 22219100 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting only one out of three treatment goals
Number of subjects: 1714
Study 19805643 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin at bedtime
Number of subjects: 16
Study 19805643 — intervention group
Group type: COMPARATOR
Intervention: Aspirin at awakening
Number of subjects: 16
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft-Gault (CG)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified MDRD (sMDRD)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: mean Cr-Ur
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft-Gault (CG) in higher CP (> 0.90; n = 44)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified MDRD (sMDRD) in higher CP (> 0.90; n = 44)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft-Gault (CG) in patients aged < or =64 (n = 44)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified MDRD (sMDRD) in patients aged < or =64 (n = 44)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft-Gault (CG) in lower CP (< or =0.90; n = 43)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified MDRD (sMDRD) in lower CP (< or =0.90; n = 43)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: mean Cr-Ur in lower CP (< or =0.90; n = 43)
Number of subjects: 87
Study 16943683 — intervention group
Group type: EXPERIMENTAL
Intervention: mean Cr-Ur in older age (>64 years; n = 43)
Number of subjects: 87
Study 15542159 — intervention group
Group type: EXPERIMENTAL
Intervention: dl-alpha tocopheryl acetate 500 mg twice a day orally plus pentoxifylline 400 mg twice a day orally
Number of subjects: 68
Study 15542159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 11379741 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated tapered pins
Number of subjects: 20
Study 11379741 — intervention group
Group type: COMPARATOR
Intervention: Standard tapered pins
Number of subjects: 20
Study 8985079 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 21
Study 8985079 — intervention group
Group type: COMPARATOR
Intervention: Control (no fibrin sealant)
Number of subjects: 21
Study 7969965 — intervention group
Group type: COMPARATOR
Intervention: Selegiline 40 mg
Number of subjects: 17
Study 7969965 — intervention group
Group type: COMPARATOR
Intervention: Selegiline
Number of subjects: 17
Study 3583073 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine at 1800 h
Number of subjects: 12
Study 3583073 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine at 2200 h
Number of subjects: 12
Study 3583073 — intervention group
Group type: COMPARATOR
Intervention: Placebo at 1800 h and 2200 h
Number of subjects: 12
Study 31535360 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight surgery (Group 1)
Number of subjects: 200
Study 31535360 — intervention group
Group type: COMPARATOR
Intervention: Routine discharge after three days (Group 2)
Number of subjects: 200
Study 29212839 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized predialysis systolic BP of 110‐140 mmHg (intensive arm)
Number of subjects: 126
Study 29212839 — intervention group
Group type: COMPARATOR
Intervention: Standardized predialysis systolic BP of 155‐165 mmHg (standard arm)
Number of subjects: 126
Study 29212839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive arm
Number of subjects: 126
Study 29212839 — intervention group
Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 126
Study 27902836 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet CBT-I (Sleep Healthy Using the Internet [SHUTi]), a 6-week fully automated, interactive, and tailored web-based program.
Number of subjects: 303
Study 27902836 — intervention group
Group type: COMPARATOR
Intervention: Internet patient education program (control group), providing nontailored and fixed online information about insomnia.
Number of subjects: 303
Study 25948863 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus atazanavir/ritonavir (ATV/r)
Number of subjects: 328
Study 25948863 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus darunavir/ritonavir (DRV/r)
Number of subjects: 328
Study 25948863 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus raltegravir (RAL)
Number of subjects: 328
Study 24245491 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention (cognitive behavioral therapy) for alcohol, anxiety, and/or depression
Number of subjects: 0
Study 24245491 — intervention group
Group type: COMPARATOR
Intervention: Usual counseling care for alcohol problems
Number of subjects: 0
Study 21961780 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR intervention
Number of subjects: 185
Study 21961780 — intervention group
Group type: COMPARATOR
Intervention: Control group (brief educational program)
Number of subjects: 185
Study 18953056 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunization against Abeta42
Number of subjects: 20
Study 18953056 — intervention group
Group type: COMPARATOR
Intervention: Unimmunized controls
Number of subjects: 20
Study 16611342 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CsA‐ME (8 mg/kg/day starting on day 0)
Number of subjects: 197
Study 16611342 — intervention group
Group type: COMPARATOR
Intervention: Delayed CsA‐ME (8 mg/kg/day starting on day 6)
Number of subjects: 197
Study 16611342 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CsA‐ME
Number of subjects: 197
Study 16611342 — intervention group
Group type: COMPARATOR
Intervention: Delayed CsA‐ME
Number of subjects: 197
Study 12659616 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 14
Study 12659616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 10755246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (300 mg bd for 7 days)
Number of subjects: 42
Study 10755246 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim‐sulphamethoxazole (TMPSMX; 160‐800 mg bd) or alternative therapy
Number of subjects: 42
Study 8610430 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fluconazole (400 mg/day)
Number of subjects: 21
Study 1360426 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent forms used in contraceptive clinical trials
Number of subjects: 0
Study 1360426 — intervention group
Group type: EXPERIMENTAL
Intervention: Readability assessment using SMOG formula
Number of subjects: 0
Study 6721969 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid blockade
Number of subjects: 148
Study 6721969 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 148
Study 6721969 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study 30726985 — intervention group
Group type: EXPERIMENTAL
Intervention: mCare app
Number of subjects: 50
Study 30726985 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care telephone
Number of subjects: 50
Study 29105987 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone Ester (KE)
Number of subjects: 15
Study 29105987 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric Dextrose (DEXT)
Number of subjects: 15
Study 25896985 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet group (n=16)
Number of subjects: 55
Study 25896985 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face group (n=14)
Number of subjects: 55
Study 25896985 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=16)
Number of subjects: 55
Study 25896985 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 55
Study 25118263 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinhole glasses
Number of subjects: 48
Study 22776066 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention (3 months intervention from an occupational therapist)
Number of subjects: 900
Study 22776066 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 900
Study 20517149 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (PTK)
Number of subjects: 25
Study 20517149 — intervention group
Group type: COMPARATOR
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 25
Study 17845111 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo-tailored intervention/no priming
Number of subjects: 210
Study 17845111 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo-tailored intervention/priming
Number of subjects: 210
Study 17845111 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention/no priming
Number of subjects: 210
Study 17845111 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention/priming
Number of subjects: 210
Study 15670980 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus high dose multiple antioxidants (ascorbic acid 6100 mg/day, dl-alpha-tocopherol 1050 mg/day, beta-carotene 60 mg/day)
Number of subjects: 136
Study 15670980 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (paclitaxel and carboplatin)
Number of subjects: 136